NEXTBio Capital Management LP
•CIK: 2038158•Filing: Q4 2025
**NEXTBio Capital Management LP** is a specialized, actively managed fund with $170M AUM, focusing on high-growth biotechnology opportunities. The portfolio maintains concentrated exposure across 23 positions, notably anchored by TERN ($22.3M) and PTGX ($20.1M). Significant allocations are also directed toward VOR ($13.1M), ZBIO ($11.7M), and STTK ($11.5M). The fund demonstrates deep conviction in key developmental assets within the life sciences sector.
Total AUM
$170.5M
QoQ Performance
N/A
Positions
23
Top 10 Concentration
70.0%
Latest Filing
Q4 2025
Top Holdings Allocation
TERN
PTGX
VOR
ZBIO
STTK
VSTM
PVLA
TERN13.1%
PTGX11.8%
VOR7.7%
ZBIO6.9%
STTK6.7%
VSTM5.9%
PVLA5.1%
XENE4.8%
📈 Biggest Buys
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other100.0%